Hoese & Co LLP
- SEC CIK
- 0001840268
- Latest filing
- Jul 14, 2026
PFE holding history
Pfizer Inc in every 13F filed by Hoese & Co LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PFE overviewAll 13F holders of PFEFull Q2 2026 holdings
- Shares (Q2 2026)
- 5,000
- Value
- $120.3K
- % of portfolio
- 0.1%
- Quarters held
- 19
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 5,000 | $120.3K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 5,000 | $140.3K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 5,000 | $124.5K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 5,000 | $127.3K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 5,000 | $121.2K | 0.1% | +5,000 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −534−100.0% | Sold out | Holders |
| Q4 2024 | 534 | $14.2K | <0.1% | +534 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −6,706−100.0% | Sold out | Holders |
| Q1 2024 | 6,706 | $178.0K | 0.2% | −710−9.6% | Reduced | Holders |
| Q4 2023 | 7,416 | $225.9K | 0.2% | −420−5.4% | Reduced | Holders |
| Q3 2023 | 7,836 | $259.8K | 0.3% | −160−2.0% | Reduced | Holders |
| Q2 2023 | 7,996 | $293.3K | 0.3% | −270−3.3% | Reduced | Holders |
| Q1 2023 | 8,266 | $335.3K | 0.4% | −960−10.4% | Reduced | Holders |
| Q4 2022 | 9,226 | $462.0K | 0.5% | 00.0% | Unchanged | Holders |
| Q3 2022 | 9,226 | $404.0K | 0.5% | −3,570−27.9% | Reduced | Holders |
| Q2 2022 | 12,796 | $671.0K | 0.8% | 00.0% | Unchanged | Holders |
| Q1 2022 | 12,796 | $662.0K | 0.7% | −1,158−8.3% | Reduced | Holders |
| Q4 2021 | 13,954 | $824.0K | 0.8% | 00.0% | Unchanged | Holders |
| Q3 2021 | 13,954 | $600.0K | 0.6% | +158+1.1% | Added | Holders |
| Q2 2021 | 13,796 | $540.0K | 0.6% | +2,220+19.2% | Added | Holders |
| Q1 2021 | 11,576 | $419.0K | 0.5% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.